The onset and extent of genomic instability in sporadic colorectal tumor progression

Por Stoler, Daniel L., Chen, Neng, Basik, Mark, Kahlenberg, Morton S., Rodriguez-Bigas, Miguel A., Petrelli, Nicholas J., Anderson, Garth R.
Publicado em 1999

Safety and Efficacy of Metallic Stents in the Management of Colorectal Obstruction

Por Stefanidis, Dimitrios, Brown, Ken, Nazario, Hector, Trevino, Hector H., Ferral, Hector, Brady, Charles E., Gross, Glenn W., Postoak, Darren W., Chadhury, Riaz, Rousseau, Dennis L., Kahlenberg, Morton S.
Publicado em 2005

Preoperative Multimodality Therapy Improves Disease-Free Survival in Patients With Carcinoma of the Rectum: NSABP R-03

Por Roh, Mark S., Colangelo, Linda H., O'Connell, Michael J., Yothers, Greg, Deutsch, Melvin, Allegra, Carmen J., Kahlenberg, Morton S., Baez-Diaz, Luis, Ursiny, Carol S., Petrelli, Nicholas J., Wolmark, Norman
Publicado em 2009

Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer T...

Por Singh, Preet Paul, Shi, Qian, Foster, Nathan R., Grothey, Axel, Nair, Suresh G., Chan, Emily, Shields, Anthony F., Goldberg, Richard M., Gill, Sharlene, Kahlenberg, Morton S., Sinicrope, Frank A., Sargent, Daniel J., Alberts, Steven R.
Publicado no Oncologist (2016)

Alcohol consumption and colon cancer prognosis among participants in North Central Cancer Treatment Group phase III trial N0147

Por Phipps, Amanda I., Shi, Qian, Limburg, Paul J., Nelson, Garth D., Sargent, Daniel J., Sinicrope, Frank A., Chan, Emily, Gill, Sharlene, Goldberg, Richard M., Kahlenberg, Morton, Nair, Suresh, Shields, Anthony F., Newcomb, Polly A., Alberts, Steven R.
Publicado no Int J Cancer (2016)

Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)

Por Lee, Adam M., Shi, Qian, Alberts, Steven R., Sargent, Daniel J., Sinicrope, Frank A., Berenberg, Jeffrey L., Grothey, Axel, Polite, Blase, Chan, Emily, Gill, Sharlene, Kahlenberg, Morton S., Nair, Suresh G., Shields, Anthony F., Goldberg, Richard M., Diasio, Robert B.
Publicado no Pharmacogenet Genomics (2016)

Effect of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Cetuximab on Survival Among Patients With Resected Stage III Colon Cancer: A Randomized Trial

Por Alberts, Steven R., Sargent, Daniel J., Nair, Suresh, Mahoney, Michelle R., Mooney, Margaret, Thibodeau, Stephen N., Smyrk, Thomas C., Sinicrope, Frank A., Chan, Emily, Gill, Sharlene, Kahlenberg, Morton S., Shields, Anthony F., Quesenberry, James T., Webb, Thomas A., Farr, Gist H., Pockaj, Barbara A., Grothey, Axel, Goldberg, Richard M.
Publicado em 2012

Comparison of FOLFIRI With or Without Cetuximab in Patients With Resected Stage III Colon Cancer; NCCTG (Alliance) Intergroup Trial N0147

Por Huang, Jocelin, Nair, Suresh G., Mahoney, Michelle R., Nelson, Garth D., Shields, Anthony F., Chan, Emily, Goldberg, Richard M., Gill, Sharlene, Kahlenberg, Morton S., Quesenberry, James T., Thibodeau, Stephen N., Smyrk, Thomas C., Grothey, Axel, Sinicrope, Frank A., Webb, Thomas A., Farr, Gist H., Pockaj, Barbara A., Berenberg, Jeffrey L., Mooney, Margaret, Sargent, Daniel J., Alberts, Steven R.
Publicado em 2013